Secondary immunodeficiencies: an overview
KS Tuano, N Seth, J Chinen - Annals of Allergy, Asthma & Immunology, 2021 - Elsevier
Objective To review the different causes of secondary immunodeficiencies and provide
clinicians with an updated overview of potential factors that contribute to immunodeficiency …
clinicians with an updated overview of potential factors that contribute to immunodeficiency …
The impact of curcumin on immune response: an immunomodulatory strategy to treat sepsis
Primary and secondary immunodeficiencies cause an alteration in the immune response
which can increase the rate of infectious diseases and worsened prognoses. They can also …
which can increase the rate of infectious diseases and worsened prognoses. They can also …
Safety considerations with biologics and new inflammatory bowel disease therapies
NSF Queiroz, M Regueiro - Current Opinion in Gastroenterology, 2020 - journals.lww.com
Safety considerations with biologics and new inflammatory bo... : Current Opinion in
Gastroenterology Safety considerations with biologics and new inflammatory bowel disease …
Gastroenterology Safety considerations with biologics and new inflammatory bowel disease …
[HTML][HTML] Serious Infections in Pediatric Inflammatory Bowel Disease 2002-2017—A Nationwide Cohort Study
JF Ludvigsson, MC Sachs, J Järås, P Malmborg… - The Journal of …, 2021 - Elsevier
Objective To assess absolute and relative risks of serious infections (resulting in inpatient
care) in children with inflammatory bowel disease (IBD) compared with the general …
care) in children with inflammatory bowel disease (IBD) compared with the general …
Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study
Background Studies have shown an association between use of tumour necrosis factor-α
(TNFα) inhibitors and increased risk of serious infection in adult inflammatory bowel disease …
(TNFα) inhibitors and increased risk of serious infection in adult inflammatory bowel disease …
Combining omalizumab with another biotherapy
AC Fougerousse, PA Becherel… - Acta Dermato …, 2019 - medicaljournalssweden.se
Our improved understanding of the chronic inflammatory diseases has enabled the
development of biologics, targeting multiple pathways, such as tumor necrosis factor (TNF) …
development of biologics, targeting multiple pathways, such as tumor necrosis factor (TNF) …
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
Background Anti-TNF therapy represented a landmark in medical treatment of ulcerative
colitis (UC). There is lack of data on the efficacy and safety of these agents in Brazilian …
colitis (UC). There is lack of data on the efficacy and safety of these agents in Brazilian …
Trends of medication usage and associated outcomes for Taiwanese patients with inflammatory bowel disease from 2001 to 2015
MT Weng, CC Tung, YT Chang, YL Leong… - Journal of Clinical …, 2018 - mdpi.com
Background: No nationwide, long-term follow-up study has assessed medication-associated
outcomes for Asian patients with inflammatory bowel disease (IBD). This study examined …
outcomes for Asian patients with inflammatory bowel disease (IBD). This study examined …
Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for primary care providers
Anticipatory care of children and adolescents with inflammat... : Current Opinion in Pediatrics
Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for …
Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for …
彌漫性軸索損傷患者血清MBP, IL-1β, IL-8 及TNF-α 水平的表達及臨床意義.
任晓兵, 钟勇, 陈广福, 王文娟… - Progress in Modern …, 2018 - search.ebscohost.com
摘要目的: 探讨弥漫性轴索损伤(DAI) 患者血清髓鞘碱性蛋白(MBP), 白细胞介素-1 茁(IL-1 茁),
白细胞介素-8 (IL-8) 及肿瘤坏死因子-琢(TNF-琢) 水平的表达及临床意义. 方法: 选取2015 年12 …
白细胞介素-8 (IL-8) 及肿瘤坏死因子-琢(TNF-琢) 水平的表达及临床意义. 方法: 选取2015 年12 …